|
1
|
Frank A, Bonney M, Bonney S, Weitzel L,
Koeppen M and Eckle T: Myocardial ischemia reperfusion injury: From
basic science to clinical bedside. Semin Cardiothorac Vasc Anesth.
16:123–132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Konstantinidis K, Whelan RS and Kitsis RN:
Mechanisms of cell death in heart disease. Arterioscler Thromb Vasc
Biol. 32:1552–1562. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen C, Jia KY, Zhang HL and Fu J: MiR-195
enhances cardiomyocyte apoptosis induced by hypoxia/reoxygenation
injury via downregulating c-myb. Eur Rev Med Pharmacol Sci.
20:3410–3416. 2016.PubMed/NCBI
|
|
4
|
Cao H, Xu H, Zhu G and Liu S: Isoquercetin
ameliorated hypoxia/reoxygenation-induced H9C2 cardiomyocyte
apoptosis via a mitochondrial-dependent pathway. Biomed
Pharmacother. 95:938–943. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McGilliard KL and Takemori AE: Alterations
in the antagonism by naloxone of morphine-induced respiratory
depression and analgesia after morphine pretreatment. J Pharmacol
Exp Ther. 207:884–891. 1978.PubMed/NCBI
|
|
6
|
Swartjes M, Mooren RA, Waxman AR, Arout C,
van de Wetering K, den Hartigh J, Beijnen JH, Kest B and Dahan A:
Morphine induces hyperalgesia without involvement of µ-opioid
receptor or morphine-3-glucuronide. Mol Med. 18:1320–1326. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Okubo S, Tanabe Y, Takeda K, Kitayama M,
Kanemitsu S, Kukreja RC and Takekoshi N: Ischemic preconditioning
and morphine attenuate myocardial apoptosis and infarction after
ischemia-reperfusion in rabbits: Role of delta-opioid receptor. Am
J Physiol Heart Circ Physiol. 287:H1786–H1791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Wang L, Li JH, Zhao HW and Zhang
FZ: Morphine alleviates myocardial ischemia/reperfusion injury in
rats by inhibiting TLR4/NF-κB signaling pathway. Eur Rev Med
Pharmacol Sci. 23:8616–8624. 2019.PubMed/NCBI
|
|
9
|
He SF, Zhu HJ, Han ZY, Wu H, Jin SY, Irwin
MG and Zhang Y: MicroRNA-133b-5p is involved in cardioprotection of
morphine preconditioning in rat cardiomyocytes by targeting fas.
Can J Cardiol. 32:996–1007. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Whelan RS, Kaplinskiy V and Kitsis RN:
Cell death in the pathogenesis of heart disease: Mechanisms and
significance. Annu Rev Physiol. 72:19–44. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hwang CK, Wagley Y, Law PY, Wei LN and Loh
HH: MicroRNAs in opioid pharmacology. J Neuroimmune Pharmacol.
7:808–819. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dong S, Cheng Y, Yang J, Li J, Liu X, Wang
X, Wang D, Krall TJ, Delphin ES and Zhang C: MicroRNA expression
signature and the role of microRNA-21 in the early phase of acute
myocardial infarction. J Biol Chem. 284:29514–29525. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheng Y, Liu X, Zhang S, Lin Y, Yang J and
Zhang C: MicroRNA-21 protects against the H(2)O(2)-induced injury
on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol.
47:5–14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren XP, Wu J, Wang X, Sartor MA, Jones K,
Qian J, Nicolaou P, Pritchard TJ and Fan GC: MicroRNA-320 is
involved in the regulation of cardiac ischemia/reperfusion injury
by targeting heat-shock protein 20. Circulation. 119:2357–2366.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu H, Li W, Zhang M, Zhu S, Zhang D and
Wang X: Inhibitory roles of miR-320 in osteosarcoma via regulating
E2F1. J Cancer Res Ther. 12:S68–S71. 2016. View Article : Google Scholar
|
|
17
|
Wang W, Yang J, Xiang YY, Pi J and Bian J:
Overexpression of hsa-miR-320 is associated with invasion and
metastasis of ovarian cancer. J Cell Biochem. 118:3654–3661. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Q and Lesnefsky EJ: A new strategy to
decrease cardiac injury in aged heart following
ischaemia-reperfusion: Enhancement of the interaction between AMPK
and SIRT1. Cardiovasc Res. 114:771–772. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tian L, Cao W, Yue R, Yuan Y, Guo X, Qin
D, Xing J and Wang X: Pretreatment with Tilianin improves
mitochondrial energy metabolism and oxidative stress in rats with
myocardial ischemia/reperfusion injury via AMPK/SIRT1/PGC-1 alpha
signaling pathway. J Pharmacol Sci. 139:352–360. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen WR, Liu HB, Chen YD, Sha Y, Ma Q, Zhu
PJ and Mu Y: Melatonin attenuates myocardial ischemia/reperfusion
injury by inhibiting autophagy via an AMPK/mTOR signaling pathway.
Cell Physiol Biochem. 47:2067–2076. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu L, Jin X, Hu CF, Li R, Zhou Z and Shen
CX: Exosomes derived from mesenchymal stem cells rescue myocardial
ischaemia/reperfusion injury by inducing cardiomyocyte autophagy
Via AMPK and Akt pathways. Cell Physiol Biochem. 43:52–68. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kosuru R, Cai Y, Kandula V, Yan D, Wang C,
Zheng H, Li Y, Irwin MG, Singh S and Xia Z: AMPK contributes to
cardioprotective effects of pterostilbene against myocardial
ischemia-reperfusion injury in diabetic rats by suppressing cardiac
oxidative stress and apoptosis. Cell Physiol Biochem. 46:1381–1397.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gu C, Li T, Jiang S, Yang Z, Lv J, Yi W,
Yang Y and Fang M: AMP-activated protein kinase sparks the fire of
cardioprotection against myocardial ischemia and cardiac ageing.
Ageing Res Rev. 47:168–175. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen K, Li G, Geng F, Zhang Z, Li J, Yang
M, Dong L and Gao F: Berberine reduces ischemia/reperfusion-induced
myocardial apoptosis via activating AMPK and PI3K-Akt signaling in
diabetic rats. Apoptosis. 19:946–957. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun Y, Jiang C, Jiang J and Qiu L:
Dexmedetomidine protects mice against myocardium
ischaemic/reperfusion injury by activating an AMPK/PI3K/Akt/eNOS
pathway. Clin Exp Pharmacol Physiol. 44:946–953. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu J, Huang W, Ren C, Wen Q, Liu W, Yang
X, Wang L, Zhu B, Zeng L, Feng X, et al: Flotillin-2 promotes
metastasis of nasopharyngeal carcinoma by activating NF-κB and
PI3K/Akt3 signaling pathways. Sci Rep. 5:116142015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou K, Fan YD, Wu PF, Duysenbi S, Feng
ZH, Du GJ and Zhang TR: MicroRNA-145 inhibits the activation of the
mTOR signaling pathway to suppress the proliferation and invasion
of invasive pituitary adenoma cells by targeting AKT3 in vivo and
in vitro. Onco Targets Ther. 10:1625–1635. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khedr RM, Ahmed AAE, Kamel R and Raafat
EM: Sitagliptin attenuates intestinal ischemia/reperfusion injury
via cAMP/PKA, PI3K/Akt pathway in a glucagon-like peptide 1
receptor-dependent manner. Life Sci. 211:31–39. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang H, Song X, Ling Y, Wang X, Yang P,
Luo T and Chen A: Puerarin attenuates myocardial
hypoxia/reoxygenation injury by inhibiting autophagy via the Akt
signaling pathway. Mol Med Rep. 15:3747–3754. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xiao R, Xiang AL, Pang HB and Liu KQ:
Hyperoside protects against hypoxia/reoxygenation induced injury in
cardiomyocytes by suppressing the Bnip3 expression. Gene.
629:86–91. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Coles JA Jr, Sigg DC and Iaizzo PA: Role
of kappa-opioid receptor activation in pharmacological
preconditioning of swine. Am J Physiol Heart Circ Physiol.
284:H2091–H2099. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peart JN, Patel HH and Gross GJ:
Delta-opioid receptor activation mimics ischemic preconditioning in
the canine heart. J Cardiovasc Pharmacol. 42:78–81. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun L, Zhao M, Yu XJ, Wang H, He X, Liu JK
and Zang WJ: Cardioprotection by acetylcholine: A novel mechanism
via mitochondrial biogenesis and function involving the PGC-1α
pathway. J Cell Physiol. 228:1238–1248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liang BT and Gross GJ: Direct
preconditioning of cardiac myocytes via opioid receptors and KATP
channels. Circ Res. 84:1396–1400. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pan Z, Sun X, Ren J, Li X, Gao X, Lu C,
Zhang Y, Sun H, Wang Y, Wang H, et al: miR-1 exacerbates cardiac
ischemia-reperfusion injury in mouse models. PLoS One.
7:e505152012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang Y, Del Re DP, Nakano N, Sciarretta S,
Zhai P, Park J, Sayed D, Shirakabe A, Matsushima S, Park Y, et al:
miR-206 mediates YAP-induced cardiac hypertrophy and survival. Circ
Res. 117:891–904. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang J, Chen L, Yang J, Ding J, Li S, Wu
H, Zhang J, Fan Z, Dong W and Li X: MicroRNA-22 targeting CBP
protects against myocardial ischemia-reperfusion injury through
anti-apoptosis in rats. Mol Biol Rep. 41:555–561. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li R, Yan G, Li Q, Sun H, Hu Y, Sun J and
Xu B: MicroRNA-145 protects cardiomyocytes against hydrogen
peroxide (H2O2)-induced apoptosis through
targeting the mitochondria apoptotic pathway. PLoS One.
7:e449072012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu LM, Di WC, Dong X, Li Z, Zhang Y, Xue
XD, Xu YL, Zhang J, Xiao X, Han JS, et al: Melatonin protects
diabetic heart against ischemia-reperfusion injury, role of
membrane receptor-dependent cGMP-PKG activation. Biochim Biophys
Acta Mol Basis Dis. 1864:563–578. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu J, Wang J, Ning Y and Chen F: The
inhibition of miR-101a-3p alleviates H/R injury in H9C2 cells by
regulating the JAK2/STAT3 pathway. Mol Med Rep. 21:89–96.
2020.PubMed/NCBI
|
|
42
|
Xiao JM, Wang JJ and Sun LL: Effect of
miR-134 against myocardial hypoxia/reoxygenation injury by directly
targeting NOS3 and regulating PI3K/Akt pathway. Acta Cir Bras.
34:e2019008022019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Luo L, Yang R, Zhao S, Chen Y, Hong S,
Wang K, Wang T, Cheng J, Zhang T and Chen D: Decreased miR-320
expression is associated with breast cancer progression, cell
migration, and invasiveness via targeting Aquaporin 1. Acta Biochim
Biophys Sin (Shanghai). 50:473–480. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pan C, Gao H, Zheng N, Gao Q, Si Y and
Zhao Y: miR-320 inhibits the growth of glioma cells through
downregulating PBX3. Biol Res. 50:312017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang T, Zou P, Wang T, Xiang J, Cheng J,
Chen D and Zhou J: Down-regulation of miR-320 associated with
cancer progression and cell apoptosis via targeting Mcl-1 in
cervical cancer. Tumour Biol. 37:8931–8940. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhu H, Jiang X, Zhou X, Dong X, Xie K,
Yang C, Jiang H, Sun X and Lu J: Neuropilin-1 regulated by miR-320
contributes to the growth and metastasis of cholangiocarcinoma
cells. Liver Int. 38:125–135. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tian ZQ, Jiang H and Lu ZB: miR-320
regulates cardiomyocyte apoptosis induced by ischemia-reperfusion
injury by targeting AKIP1. Cell Mol Biol Lett. 23:412018.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Alcantara D, Timms AE, Gripp K, Baker L,
Park K, Collins S, Cheng C, Stewart F, Mehta SG, Saggar A, et al:
Mutations of AKT3 are associated with a wide spectrum of
developmental disorders including extreme megalencephaly. Brain.
140:2610–2622. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chin YR, Yoshida T, Marusyk A, Beck AH,
Polyak K and Toker A: Targeting Akt3 signaling in triple-negative
breast cancer. Cancer Res. 74:964–973. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Carloni S, Girelli S, Buonocore G, Longini
M and Balduini W: Simvastatin acutely reduces ischemic brain damage
in the immature rat via Akt and CREB activation. Exp Neurol.
220:82–89. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yao H and Han X and Han X: The
cardioprotection of the insulin-mediated PI3K/Akt/mTOR signaling
pathway. Am J Cardiovasc Drugs. 14:433–442. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Song HP, Chu ZG, Zhang DX, Dang YM and
Zhang Q: PI3K-AKT pathway protects cardiomyocytes against
hypoxia-induced apoptosis by MitoKATP-mediated mitochondrial
translocation of pAKT. Cell Physiol Biochem. 49:717–727. 2018.
View Article : Google Scholar : PubMed/NCBI
|
